CAR-T Therapies: Filing Trends, Opportunities,​ and Challenges to Patentability

4:00 PM - 4:45 PM (EDT), Wednesday, June 16, 2021
Search General Info
Search Education
Search Partnering Companies
The emerging field of CAR T cell therapy has the potential to change the way we treat cancer. And while there are many opportunities, there are also challenges—especially with regards to patents. Panelists will discuss developments in the field, as well as how to file a successful patent application, with specific examples of claim drafting and key differences between the European and the U.S. systems. Attendees will come away with insight into IP strategies, the interests and expectations of industry, and what’s ahead for CAR T cell patenting.
Director HBC | Directorate
European Patent Office
HGF Limited
Associate General Counsel
Gilead Sciences